Review immune response of targeting CD39 in cancer

• Үндсэн зохиолчид: Yao Liu (Зохиогч), Zhongliang Li (Зохиогч), Xiaoguang Zhao (Зохиогч), Jing Xiao (Зохиогч), Jiacheng Bi (Зохиогч), Xian-Yang Li (Зохиогч), Guokai Chen (Зохиогч), Ligong Lu (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2023-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract The ATP-adenosine pathway has emerged as a promising target for cancer therapy, but challenges remain in achieving effective tumor control. Early research focused on blocking the adenosine generating enzyme CD73 and the adenosine receptors A2AR or A2BR in cancer. However, recent studies hav...